Abstract:Abstract Introduction There are currently different management guidelines for patients undergoing elective total hip arthroplasty (THA) or total knee arthroplasty (TKA) that are on long-term anticoagulation. The timing of discontinuation and restarting the anticoagulation is challenging during the postoperative care, which often involves general practitioners and physiotherapists. Methods The systematic review followed the PRISMA guidelines and included 3 databases: PubMed/MEDLINE, EMBASE, and Web of Science Core Collection. It was registered in the International Prospective Register for Systematic Reviews and Meta-analysis (PROSPERO) under the registration number: CRD42023408906. The risk of bias assessment was performed using the Methodological index for non-randomized studies (MINORS) criteria. Results Six retrospective studies involving 727 patients with therapeutic anticoagulation (1,540 controls) for elective THA, TKA and revision arthroplasty have been included. The follow-up ranged from 30 days to 1 year postoperatively. All studies evaluated outcomes of warfarin therapeutic anticoagulation versus prophylactic dosages of one or more of the following: warfarin, aspirin, low-molecular-weight heparin (LMWH) and unfractionated low-dose heparin (UFH). One study did not discontinue therapeutic anticoagulation. Two studies reported no significant differences in complications between groups, whilst 3 studies had significantly higher rates of superficial wound infections, revision surgeries, postoperative haematomas, and prosthetic joint infections (PJI). Conclusion Different anticoagulation-related perioperative management strategies achieve different outcomes following elective arthroplasty in patients with therapeutic chronic anticoagulation. There is contradictory evidence regarding the need for the discontinuation of therapeutic warfarin. Retrospective data showed that individual risk stratification with multi-modal prophylaxis resulted in minimal complications. Level of Evidence Systematic Review of Level III studies.

Anticoagulant therapy in orthopedic surgery – a review on anticoagulant agents, risk factors, monitoring, and current challenges

Direct Oral Anticoagulants: How Do These Drugs Work, How to Monitor, and What is Their Role in Orthopaedic Surgery.

Strategies for Perioperative Anticoagulant Reversal in Orthopedic Surgery: A Review

New oral antithrombotic agents for the prevention of deep venous thrombosis and pulmonary embolism in orthopedic surgery

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants

Challenges to Laboratory Monitoring of Direct Oral Anticoagulants

Direct Oral Anticoagulants: Laboratory Challenges and Antidotes

Review of Anticoagulant Prescribing Patterns in New Onset Atrial Fibrillation After Cardiac Surgery

Update on Venous Thromboembolism in Orthopaedic Trauma Surgery

Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?

Perioperative Management of Direct Oral Anticoagulants in Cardiac Surgery: Practice Recommendations Based on Current Evidence

Updates in Anticoagulation Therapy Monitoring

Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants

Risks of major bleeding and venous thromboembolism in patients undergoing total hip or total knee arthroplasty using therapeutic dosages of DOACs

Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty

Perioperative Management of Traditional and Direct Oral Anticoagulants in Hip Fracture Patients

Outcomes of different perioperative management strategies of patients on chronic anticoagulation in elective total hip and knee arthroplasty: a systematic review

Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors

Advances in DVT prophylaxis and management in major orthopaedic surgery

Oral anticoagulation: preparing for change

Predictors of direct oral anticoagulant concentrations in the trauma population